| ||
|
Isoflavone Isoflavones belong to a class of compounds known as flavonoids. Intake of soy isoflavones regulates cholesterol and triglyceride levels in PPAR-alpha-dependent and independent manner. Mezei, O., Ross-Viola, J., Mullen, E., Li, Y., and Shay, N.F. Abstract #586.3. Allergic reaction to medication. SCIENTIFIC NAMES: Glycyrrhiza glabra COMMON NAMES: Licorice COMMON USES: Infections, inflammation, menstrual disorders, ulcers, canker sores, herpes, eczema, and psoriasis Licorice is an herb with antiallergic, antiviral, antibacterial, and expectorant properties among others. Licorice root is one of the most used and investigated herbal medicines. Its medicinal use dates back several thousand years, and it has historically been used as a mild laxative, and for the treatment of ulcers, asthma, insomnia, infections, and abdominal pain. There are three main clinical uses of licorice: oral preparations containing glycyrrhetinic acid, deglycyrrhizinated licorice or DGL, and topical preparations with glycyrrhetinic acid. The first preparation is used predominately in viral infections, inflammation, and menstrual disorders like PMS. The second fights ulcerative conditions, and the last, topical applications, can be used for herpes and similar problems. Licorice stimulates interferon, the body's natural antiviral compound, into increased activity. Glycyrrihizin, a property of licorice also inhibits the growth of certain DNA and RNA viruses like herpes complex. And besides fighting the common cold by stimulating the immune system, licorice has been studied extensively for its effects on the immune reactions in AIDS patients. Patients given glycyrrhizin showed almost immediate improvement in immune function--increased helper T cell counts, improved helper-tosuppressor T cell ratios and better function in the liver. The estrogenic activity of licorice is also impressive. The effects licorice has on estrogen metabolism are two-fold. If estrogen levels in the body are above normal, licorice will prevent production to help normalize levels; however, if estrogen levels fall below the norm, licorice will also stimulate increased estrogen production to bring the levels back into equilibrium. This is due to the isoflavone content in licorice. There have also been numerous studies and a great deal of research done on the beneficial effects of licorice on inflammation and ulcer conditions, as well as the positive results as a topical preparation for herpes and similar problems. Licorice reduces swelling, encourages healing and speeds up the time it takes for healing to occur. Taking one to two grams of the powered root three times a day is a safe dose. However, licorice may cause sodium and water retention or hypertension. If you are prone to high blood pressure, or have a history of hypertension or renal failure get the advice of a health care professional before beginning licorice supplementation. TH. Table 15: selected grade 3 4 adverse events in 2 large comparative studies of ddc table from drugs 1997; 53 6 ; : 1071. Rod-shaped bacterium that resists decolorizing chemicals after staining, a property termed "acid-fastness." M. tuberculosis is transmitted most commonly by the airborne route to the lungs, where it survives well, causes areas of granulomatous inflammation, and, if not dormant, causes cough, fever, and hemoptysis. The acid-fast bacterium Mycobacterium avium-intracellulare is a common cause of infection in clients with AIDS. Culture of sputum is necessary to confirm the diagnosis of tuberculosis and for sensitivity studies for drug therapy. The sensitivity of sputum smears for tuberculosis, however, is only 50 and isoniazid. 2. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract ICE ; study: a randomized controlled trial. JAMA. 2003; 290: 207-214. Kligler B. Black cohosh. Fam Phys. 2003; 68: 114-116. Sun J. Morning evening menopausal formula relieves menopausal symptoms: a pilot study. J Altern Complement Med. 2003; 9: 403-409. Albertazzi P, Bottazzi M, Purdie DW. Gabapentin for the management of hot flushes: a case series. Menopause. 2003; 10: 214-217. IMS prescribing data for the 12-month period ending September 2003. 7. Stevens RE, Roy P, Phelps KV. Evaluation of single- and multiple-dose pharmacokinetics of synthetic conjugated estrogens, A Cenestin ; tablets: a slow-release estrogen replacement product. J Clin Pharmacol. 2002; 42: 332-341. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-333. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women. JAMA. 2003; 289: 2673-2684. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in post menopausal women. JAMA. 2003; 289: 2651-2662. National Heart Lung and Blood Institute and Giovanni Lorenzini Medical Science Foundation. "Best Clinical Practices." Chapter 13 from "International Position Paper on Women's Health and Menopause: A Comprehensive Approach." March 2002. 12. Thompson B, Hart SA, Durno DR. Menopausal age and symptomatology in general practice. J Biol Sci. 1973; 5: 71-82. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril. 2001; 75: 1065-1079. VI. Workload Measurement Please refer to Daily Provider Time Guidelines. VII. Equipment Management & Safety A. The primary professional is responsible for transporting and installing the Monitoring System in the patient's home. B. All staff shall be knowledgeable regarding the safe transport, cleaning, and storage of the Monitoring System. 1. Prior to transporting the Monitoring System to a patient's home: a. Notify Central Station clinician and Admin Support of new patient and time and day wk that patient will be monitoring b. Inspect each component of the Monitoring System to insure that all surfaces are clean and free from physical damage c. Assemble Monitor on a clean, dry surface and verify that the Monitor is operating properly d. Sign out Monitor scale on Inventory Log sheet e. Pre-program the Monitor to facilitate home installation f. Document necessary information on the Equipment Loan and Monitor Installation Form g. Transport monitor and all accessories in a clean plastic bag and in a designated carrying case h. Return carrying case to EMP unit 2. Discontinuation of Monitoring System services: a. Notify Central Station clinician of discontinuation of monitoring b. Consider all equipment and accessories used in the home as contaminated 1 ; Place monitoring system and any peripheral medical devices in a plastic bag. Tie bag securely, label "dirty, " and transport for disinfection in designated carrying case 2 ; Deliver contaminated equipment to designated "dirty area" c. Clean and disinfect contaminated equipment: 1 ; Wearing gloves, remove contaminated equipment from bag 2 ; Detach all accessories and peripheral medical devices 3 ; Clean peripheral medical devices per manufacturer's instructions 4 ; Clean surfaces of monitor and accessories with a soft cloth moistened in a mild, non-abrasive soap solution 5 ; DO NOT spray any cleaners on or into the unit 6 ; DO NOT immerse any accessories in water or any other liquid 7 ; To disinfect, wipe the surfaces with isopropyl alcohol or designated disinfectant and then wipe with soft cloth moistened in water 8 ; Air dry unit and accessories before placing in plastic bag 9 ; Check when yearly maintenance is due 10 ; Label equipment appropriately and store in plastic bag in designated clean area for next use and vasodilan, for example, soy isoflavones extract. This drug may make you dizzy or cause blurred vision; use caution engaging in activities requiring alertness or clear vision such as driving or using machinery. Analysis found that those subjects who consumed the most ALA were approximately 20 percent less likely to die from CHD as compared to those whose consumption was low.24 The ALA intake difference between the high and low consumers was only 1.2 g d; three cups of full-fat soymilk provide approximately this amount. The means by which ALA reduces CHD risk have not been established, but omega-3 fatty acids in general are thought to reduce risk of cardiac arrhythmia.25 Interestingly, one recent study found that soy oil was almost as effective as fish oil in increasing heart rate variability, which decreases risk of arrhythmia.26 Conclusions Protein Content of Soyfoods Substantially reducing CHD risk through Serving lifestyle modification requires making Food Kcal Protein g ; size comprehensive changes. No single food Tofu, silken, or nutrient is sufficiently potent to 1 slice 32 5.3 lite firm produce meaningful reductions in risk. It Tofu, raw, is clear however that the established cup 183 19.9 firm coronary benefits of soy protein Soy burger 1 patty 125 reductions in triglycerides and LDLC, Soynuts cup 203 15.2 and increased HDLC ; in combination Edamame cup 127 11.1 with the possible benefits such as Soymilk 1 cup 127 5.5 reduction in blood pressure and improved endothelial health ; justify recommendations to include soyfoods in a heart-healthy diet. For cholesterol reduction, an intake of 25 g soy protein is recommended see Protein Content of Soyfoods table ; . References 1. Meeker DR, Kesten D. Effect of high protein diets on experimental atherosclerosis of rabbits. Arch Pathol 1941; 31: 147-162. Meeker DR, Kesten HD. Experimental atherosclerosis and high protein diets. Proc Soc Exp Biol Med 1940; 45: 543-545. Hodges RE, Krehl WA, Stone DB, Lopez A. Dietary carbohydrates and low cholesterol diets: effects on serum lipids on man. J Clin Nutr 1967; 20: 198-208. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276-282. Food and Drug Administration. Food labeling, health claims, soy protein, and coronary heart disease. Fed Reg 1999; 57: 699-733. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. J Clin Nutr 2005; 81: 397-408. Gardner CD, Coulston A, Chatterjee L, Rigby A, Spiller G, Farquhar JW. The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial. Ann Intern Med 2005; 142: 725-733. Anderson JW. Diet first, then medication for hypercholesterolemia. JAMA 2003; 290: 531-533 and ketorolac. Isoflavone priceIndex stroke 196 treatment, Tab. 809 vertigo 708 vestibular 812 miliary tuberculosis, meningoencephalitis 91, Fig. 91 Millard-Gubler syndrome, Tab. 174 Miller Fisher syndrome 581 mini-mental status test 362, Fig. 362, Tab. 363 Minor's iodine-starch test 746 mirror focus 526 mismatch 693 mitochondrial classification, Tab. 895 diseases, clinical manifestations, Tab. 896 DNA 895 encephalomyopathies 895 encephalopathy 296, 299 myopathies, classification, Tab. 895 Miyoshi type myopathy 872 MLF 641 MNGIE syndrome 343 MNGIE syndrome 898 Mbius syndrome 662, 678 Mbius' sign 318 modified NIH stroke scale 942 modified Rankin scale, stroke 941 Moersch-Woltman syndrome 883 Mondini syndrome, Tab. 684 monomelic amyotrophy 432 mononeuritis multiplex 606 mononeuritis multiplex 607 mononeuropathy, diabetic 602 monoparesis 3 morbus sacer 493 Morgagni-BarraquerSimon's syndrome 462 Morgagni-Morel syndrome 820 Moro reflex, Tab. 27 Morquio's disease 291 Morton's metatarsalgia 844 Morton's toe 796 Morvan's fibrillary chorea 274 motility, principles, ocular 641 motion sickness 693 motor deficits, grading, Tab. 747 motor development normal 15 childhood, Fig. 28 motor neuron disease 434 motor neuropathy, multifocal conduction block 613 motor phenomena, nonepileptic 556 motor unit 425, 742, Fig. 855 movement disorders, Tab. 30 medication induced, Tab. 306 moyamoya 198 MPTP 245 MR images, signal intesities, Tab. 136 MRA, Fig. 137 MRI 134, Tab. 135 functional 138, Fig. 139 physical principles, Fig. 133 ring enhancement, Tab. 94 MS see multiple sclerosis mucolipidoses 291 mucopolysaccharidoses 291 and ketotifen. The isoflavones thus help to balance oestrogen levels in the body, reducing the hormone-related complaints associated with menopause.
Clinical trials are still at an early stage for genistein and related compounds, with very few results published, even of a preliminary nature. A Phase I trial gave a form of genistein: 'B43-genistein' - stated to be a tyrosine kinase inhibitor - to 15 acute or chronic leukaemia patients who had 'failed standard therapy' AACR, 1999 ; . The report states cites the drug's 'acceptable toxicity profile' and improvement or remission in three patients. It is not a peer-reviewed paper but a conference presentation abstract, and does not reveal the nature of the compound, the quantities administered, the route of administration, the duration of the trial or which patients appeared to benefit. Another paper - again not a scientific journal article - reports a trial which measured levels of prostate-specific antigen PSA ; in 30 clinically stable prostate cancer patients Barkin et al., 2000 ; . It states that patients using a fermented soya drink for six months had a slower PSA increase than controls and patients given concentrated isoflavones, but PSA responses did not correlate with plasma genistein levels. EPS genistein levels and cancer progression are not reported. PSA levels do not necessarily correlate with cancer proliferation Adlercreutz, 2002 ; . An original research communication on prostate cancer states that twenty patients treated for 28-56 days with high doses of genistein 300-600 mg per day ; showed no significant genotoxicity arising from the treatment Miltyk et al., 2003 ; . The researchers report that there were no rearrangements of the MLL gene see Section 6 ; in the three patients examined for such mutations. Plasma genistein levels did not exceed 0.32 M despite the very high intake, although a level of 27.1 M was recorded for 'total genistein', apparently meaning conjugated and unconjugated forms combined. Again, EPS genistein levels are not reported. Clearly we must await more clinical trial reports before any firm conclusions can be drawn for genistein and or other phytoestrogens as cancer treatments, and many such studies are ongoing and recruiting and lamictal.
I take som vegetable essential fatty oils mixture called udos choise, for example, isoflavones for men. © 2007 |